HPV 18 What’s? Why This Strain Is Linked to Cervical Cancer

HPV 18 or Human Papillomavirus Type 18, is classified as a high-risk strain due to its strong association with cancer development—particularly adenocarcinoma of the cervix. Among over 150 HPV types, type 18 is one of the most dangerous, silently affecting healthy tissues and potentially leading to serious outcomes.

Most HPV 18 infections are asymptomatic and may be cleared naturally by a healthy immune system. However, undetected and unmanaged infections can progress to precancerous or cancerous stages. That’s why it’s critical to understand how HPV 18 spreads, presents symptoms (if any), is diagnosed, and most importantly—how it can be prevented through safe practices and vaccination.

What is HPV 18?

HPV 18, or Human Papillomavirus Type 18, is a high-risk strain of the Human Papillomavirus family, strongly associated with cervical cancer—particularly adenocarcinoma, which develops in the glandular cells of the cervix rather than the surface epithelium.

What makes HPV 18 especially dangerous is its ability to persist in the body without showing symptoms. Many people are unaware they are infected, allowing the virus to silently progress to precancerous or cancerous conditions over time.

According to the World Health Organization (WHO), HPV 16 and 18 together are responsible for more than 70% of cervical cancer cases worldwide, making them a major public health concern that demands proactive screening and prevention.

HPV 18 vs. Other HPV Strains

Human Papillomavirus (HPV) includes more than 150 distinct strains, each posing varying levels of health risk. Low-risk strains often cause genital or skin warts, while high-risk strains—most notably HPV 16 and 18—are linked to cancer development, particularly cervical cancer.

HPV 18 is distinct for its strong association with adenocarcinoma, a form of cervical cancer that affects the glandular cells inside the cervix. This type is typically more difficult to detect using standard Pap smears, compared to squamous cell carcinoma commonly caused by HPV 16.

Another significant difference lies in how HPV 18 often causes no visible symptoms, such as warts or lesions. As a result, many individuals remain unaware they are infected, delaying diagnosis and increasing the likelihood of progression to cancerous stages.

How HPV 18 Spreads

HPV 18 spreads primarily through skin-to-skin contact, especially during sexual activity. This includes vaginal, anal, and oral sex, as well as intimate contact involving the genital skin—even without penetration or visible lesions.

One of the major concerns with HPV 18 is that it can be transmitted even when the infected person shows no symptoms. The virus may be present and transmissible during its latent phase, before any clinical signs appear, making unknowing transmission a significant public health issue.

There are also rare cases of vertical transmission, where an HPV-infected mother passes the virus to her baby during vaginal delivery. Although uncommon, this route of transmission underscores the need for careful prenatal evaluation in pregnant women known to carry HPV.

How HPV 18 Leads to Cancer

Once HPV 18 infects the body, it targets the epithelial cells of the cervix and integrates its viral DNA into the host’s genome. Key viral genes—E6 and E7—disrupt the body’s natural cell regulation by interfering with tumor suppressor proteins such as p53 and retinoblastoma protein (Rb).

The E6 protein binds to and degrades p53, which normally functions to control cell division and trigger apoptosis (programmed cell death) when abnormalities arise. Without functional p53, damaged cells can proliferate unchecked. Meanwhile, E7 binds to Rb, releasing transcription factors that allow cells to divide uncontrollably.

Persistent infection with HPV 18, particularly in individuals with weakened immune systems, increases the likelihood of these cellular changes becoming permanent. Over time, this can lead to the development of cervical cancer or other HPV-related malignancies.

High-Risk Groups for HPV 18 Infection

While HPV 18 can infect individuals of any age or gender, certain populations are at greater risk for contracting the virus and developing HPV-related cancers. These high-risk groups include:

• Women over the age of 25, especially those who have not received the HPV vaccine
• Individuals who began sexual activity at a young age or have multiple sexual partners
• People who do not consistently use condoms during sexual activity
• Immunocompromised individuals, such as those with HIV or undergoing immunosuppressive treatment
• Women who smoke regularly, which can impair cervical immune defenses
• Those with a family history of cervical cancer

Understanding your risk status is crucial for early intervention, including timely screening and preventive vaccination.

Symptoms of HPV 18 Infection to Watch For

HPV 18 often causes no noticeable symptoms in its early stages, which is why many individuals remain unaware of their infection. This silent nature allows the virus to persist and potentially lead to precancerous changes or cancer. However, as the virus begins to affect cervical tissue, certain signs may become apparent:

• Abnormal vaginal discharge with a foul odor or blood
• Bleeding after intercourse or between menstrual periods
• Pain or discomfort during sexual activity
• Presence of genital warts or growths around the vulva, vagina, or anus
• Chronic pelvic pain without a clear cause

These symptoms are not exclusive to HPV 18, but if you belong to a high-risk group and experience any of them, you should consult a physician for further evaluation.

Accurate Methods to Detect HPV 18

Accurate detection of HPV 18 is critical for early intervention and cancer prevention, especially in high-risk individuals. Several diagnostic methods are currently available, each with specific strengths for identifying both early-stage infection and cellular abnormalities:

• Pap Test (Pap Smear): Screens for abnormal cervical cells but does not identify HPV strain types
• HPV DNA Test: Detects HPV’s genetic material directly with high precision, and can specify whether HPV 16 or 18 is present
• ThinPrep Pap Test: A more precise version of the Pap test, enhancing sample collection and analysis
• Colposcopy: Uses a magnifying device to closely examine the cervix for abnormal or suspicious tissue
• Acetic Acid Test: Applies acetic acid to highlight areas of abnormal cells, which turn white under inspection

These tests are often used in combination to ensure accurate diagnosis, especially when abnormalities are found during initial screening.

Treatment and Management for HPV 18 Infections

While there is currently no cure to eliminate HPV 18 from the body, treatment focuses on managing the infection, preventing disease progression, and supporting the immune system. Effective care involves regular monitoring and adopting a healthy lifestyle.

Key aspects of HPV 18 care include

• Ongoing monitoring: Regular Pap smears and HPV DNA tests to track any cellular abnormalities
• Treating abnormal cells: If precancerous lesions are detected, doctors may recommend cryotherapy, LEEP (Loop Electrosurgical Excision Procedure), or laser ablation
• Strengthening the immune system: Eat antioxidant-rich foods, exercise regularly, sleep well, and avoid smoking
• Condom use: To reduce the risk of transmitting the virus to sexual partners
• Education and support: Psychological and informational support is vital to help patients manage anxiety and understand their condition

Proper care not only lowers cancer risk but also improves overall quality of life for individuals living with HPV 18.

Effective Ways to Prevent HPV 18 Infection

HPV 18 infection can be effectively prevented through a comprehensive approach that includes vaccination, safe sexual practices, and regular screenings—especially for those in high-risk groups.

1. HPV Vaccination: Vaccines like Gardasil 9 offer over 90% protection against HPV 16 and 18. Vaccination is most effective when given before the onset of sexual activity, particularly in adolescents aged 9–14.
2. Safe Sexual Behavior: Use condoms consistently, avoid having multiple sexual partners, and delay the initiation of sexual activity when possible.
3. Cervical Cancer Screening: Women aged 25 and older should undergo regular Pap smears and HPV DNA testing, even in the absence of symptoms.

These preventive strategies not only reduce the risk of infection but also help significantly lower the long-term incidence of HPV 18-related cancers.

HPV Vaccines and Their Role in Preventing Type 18 Infection

The HPV vaccine is one of the most effective tools for preventing HPV type 18, a major cause of cervical adenocarcinoma. Currently, two widely approved vaccines are available:

• Gardasil 9: Offers protection against 9 HPV types, including high-risk types 16 and 18
• Cervarix: Specifically targets HPV 16 and 18

The recommended vaccination schedule is:

• Ages 9–14: Two doses administered over six months
• Ages 15 and older: Three doses over a six-month period

Although the vaccine cannot treat existing infections, it provides strong protection against future infections. It is most effective when administered before sexual debut, but sexually active individuals can still benefit from vaccination.

Common Myths About HPV 18 That Need to Be Corrected

Despite increased awareness, many misconceptions about HPV 18 persist—leading to neglect in prevention and proper care. Correcting these myths is crucial for making informed health decisions.

Examples of common misconceptions:

• “HPV only affects women.” Fact: Men can also contract HPV 18 and are at risk for anal and penile cancers.
• “If I get vaccinated, I don’t need screening.” Fact: Vaccines don’t cover all HPV types. Regular screenings remain essential.
• “No symptoms means no infection.” Fact: HPV 18 often remains asymptomatic while still causing cellular damage and spreading to others.
• “Getting HPV means I will get cancer.” Fact: Most HPV infections do not lead to cancer, especially when managed with regular monitoring and a healthy immune system.

Dispelling these myths is a vital step in empowering individuals to take control of their sexual and reproductive health.

Frequently Asked Questions About HPV 18

To provide accurate and accessible information, here are common questions about HPV 18 along with reliable medical responses:

1. Q: How is HPV 18 transmitted?
   A: Through sexual contact, including skin-to-skin contact—not just penetrative sex.
2. Q: Can HPV 18 be cured?
   A: There is no direct cure, but most healthy immune systems can clear the virus naturally over time.
3. Q: Should men get tested for HPV 18?
   A: While screenings focus on women, men—especially those who have sex with men—may benefit from testing or vaccination.
4. Q: Can you still get HPV 18 after vaccination?
   A: Vaccines are highly effective but not absolute. Safe sex and regular screenings remain important.
5. Q: Can someone get HPV 18 again after clearing it?
   A: Yes. Reinfection is possible through a new partner or if the immune system fails to control the original infection.

Conclusion

HPV 18 remains one of the most silent but serious threats to long-term health. It can persist in the body without symptoms while gradually increasing the risk of cellular abnormalities and cancer development.

Vaccination, safe sexual practices, and routine health screenings offer the most effective defense against HPV 18. Regardless of gender, being informed and proactive is essential in reducing risk and safeguarding reproductive health.

• Facebook
• Twitter
• Line